Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04454021
Other study ID # wjqsportsmed163
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 10, 2020
Est. completion date March 10, 2020

Study information

Verified date June 2020
Source Peking University Third Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study was to investigate the change in muscle volume around the hip in patients with unilateral femoro-acetabular impingement (FAI) after arthroscopy.


Description:

We performed a retrospective review of magnetic resonance imaging (MRI) data of FAI patients who underwent hip arthroscopy between January 1, 2016, and July 1, 2018. "Image J" with an embedded region-of-interest (ROI) tool was used to calculate the cross-sectional area (CSA) of muscles on MRI. Wilcoxon signed-rank test was used to determine the differences between preoperative and postperative hip muscle CSA. The correlations of change in muscle CSA with age, gender, BMI, pain level, preoperative symptom duration, and multiple validated patient-reported outcomes were also analyzed with a spearman rank correlation test.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date March 10, 2020
Est. primary completion date March 10, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- (1) Age 18-50 years; (2) symptoms, physical examination, imaging evidence in accordance with FAI; (3) symptoms that were not alleviated by nonsurgical treatment; (4) the operation is performed by the same senior operator.

Exclusion Criteria:

- (1) bilateral symptoms; (2) revision surgery; (3) advanced osteoarthritis; (4) acetabular dysplasia; (5) history of hip and knee joint disease and operation; (6) osteonecrosis of hip; (7) sacroiliac joint disease

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
hip arthroscopy
hip arthroscopy was performed when symptoms were not alleviated by nonsurgical treatment

Locations

Country Name City State
China Jianquan Wang Beijing Haidian District

Sponsors (1)

Lead Sponsor Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in muscle volume after hip arthroscopy hip muscle cross-sectional area of patients with unilateral FAI at least two years after hip arthroscopy